Our mission

To help people live active, healthy lives by increasing their access to early diagnosis of osteoporosis.

Our purpose

Supporting healthy ageing by increasing access to
osteoporosis diagnosis.

Our vision

A world without fragility fractures.

Meet the Team

Board Members

Dr. Paul Scott
Dr. Paul Scott
CEO

Paul leads the technical development at IBEX and has a strong experimental background, with experience in product development, project management and X-ray physics.

The IBEX Team

Ben Crone
Ben Crone
Lead Research Scientist

Ben has passion for advancements in medical technology from previous projects and is now focused on the commercialisation of the Trueview software. Outside work, Ben enjoys cycling and playing bass guitar.

Dr. Ben Lopez
Dr. Ben Lopez
Technical Director

Ben’s role at IBEX is quite varied, his core work is on the methodology behind Trueview, but, Ben also dives into some strategy. He plans future updates to IBEX’s capabilities, thinks of new ideas and applications, writes papers, health economics, and classical statistical analysis for publications.

Dr. Corentin Schreiber
Dr. Corentin Schreiber
Principal Software Engineer

Corentin holds a PhD in astrophysics and joined IBEX in 2019 to optimise the performance of the IBEX software back-end

Dr. Paul Scott
Dr. Paul Scott
CEO

Paul leads the technical development at IBEX and has a strong experimental background, with experience in product development, project management and X-ray physics.

Dr. Richard McWilliam
Dr. Richard McWilliam
Lead Research Scientist

Richard leads IBEX R&D into image processing techniques. Richard has researched into digital holographic imaging for photolithography and self-repairing strategies for electronic systems

Jordan Nelson
Jordan Nelson
Software Engineer

As part of the software team, Jordan supports development of the IBEX BH product and also maintains our IT infrastructure.

Kurt Scott
Kurt Scott
Business and Regulatory Affairs Manager

Overseeing day to day management of the operational side of the business, Kurt leads the securing of grants and is vital in clinical trial planning, certification and marketing communications. He is also responsible for the quality and regulatory affairs of the business, overseeing operation of our EU MDR and ISO13485 certified quality managed system.

Investors and Partners

IBEX is backed by leading Venture Capital and Corporate investors and is grateful for additional financial and business support through grants from InnovateUK, Business Durham, and the European Union.

Through our partnership with Agfa Radiology Solutions, IBEX BH is now available to healthcare providers under their DensityScan brand.

IBEX maintains strong links with Durham, Newcastle, Exeter Universities, and, the NHS Trusts of Newcastle-upon-Tyne, South Tees, Gateshead and Royal Cornwall. We also work alongside leading osteoporosis not-for-profit organisations such as the Royal Osteoporosis Society and the International Osteoporosis Foundation.

Patents

IBEX technology is protected by the following granted patents:

GB2563115; GB2589643;

US10588592; US10820878;

JP6598087;

ZL 2015 8 0063381.0 (China)

Registered Trademarks:

“IBEX”, IBEX TRUEVIEW” and the IBEX Goat Logo are registered trademarks in the UK, registration numbers UK00003274184, UK00003274187, and UK00003274225 respectively.

Accreditation

IBEX is accredited to ISO 13485:2016 and the EU MDR and works to the Medical Device Software standard IEC 62304:2006 and the Medical Device Risk Management Standard ISO 14971:2019. The IBEX Quality Management System is aligned to MDR 2017/745 and MDR (UK) 2002.